V 073

Drug Profile

V 073

Alternative Names: pocapavir; SCH-48973; V-073

Latest Information Update: 25 Aug 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Schering-Plough
  • Developer ViroDefense
  • Class Antivirals; Small molecules
  • Mechanism of Action Capsid protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Poliomyelitis

Most Recent Events

  • 25 Aug 2015 No recent reports on development identified - Phase-II for Poliomyelitis in Sweden (PO)
  • 19 Dec 2012 ViroDefense completes a phase II trial in Poliomyelitis in Sweden (EudraCT2011-004804-38)
  • 13 Dec 2011 Phase-II clinical trials in Poliomyelitis in Sweden (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top